rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Remus Pharmaceuticals Ltd. - Research Center
Group () BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 1.09 1.00 0.01 0.01
Share application money - - - -
Preference share capital - - - -
Reserves & surplus 18.05 5.43 3.04 2.01
Loan funds
Secured loans 7.94 0.19 0.28 0.36
Unsecured loans - - - -
Total 27.08 6.62 3.33 2.38
Uses of funds
Fixed assets
Gross block 3.49 0.79 0.72 0.65
Less : revaluation reserve - - - -
Less : accumulated depreciation 0.94 0.48 0.33 0.15
Net block 2.54 0.31 0.39 0.50
Capital work-in-progress 0.02 - - -
Investments 20.62 3.07 0.07 -
Net current assets
Current assets, loans & advances 11.48 12.53 10.59 4.80
Less : current liabilities & provisions 7.58 9.29 7.72 2.92
Total net current assets 3.90 3.25 2.87 1.88
Miscellaneous expenses not written - - - -
Total 27.08 6.62 3.33 2.38
Notes:
Book value of unquoted investments 20.62 3.07 - -
Market value of quoted investments - - - -
Contingent liabilities 94.36 - - -
Number of equity sharesoutstanding (Lacs) 10.85 10.00 0.10 0.10
Close
Add Remus Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Remus Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close